Genomics of pulmonary arterial hypertension: implications for therapy.

Heart Failure Clinics
Mark W GeraciRubin M Tuder

Abstract

Pulmonary arterial hypertension (PAH) remains a vexing clinical disease with no cure. Despite advances and the discovery of a gene (BMPR2) associated with many of the hereditary forms of the disease, and some cases not previously known to be inherited, the reasons for mutations in this gene as a cause remain somewhat elusive. Clearly, a complex interplay exists between genetic alterations, environmental exposures (including infections), and disease development. This article addresses the advances in the genetics of PAH, including the identification of genetic etiologies and modulators, and the role of genetics in predicting disease progression and targeting therapeutics.

References

Sep 1, 1992·The American Journal of Medicine·R A IsernF C Arnett
Feb 1, 1992·Proceedings of the Society for Experimental Biology and Medicine·P M HassounB L Fanburg
Dec 1, 1989·American Journal of Respiratory Cell and Molecular Biology·D B BadeschK R Stenmark
Jan 1, 1988·Histopathology·D HeathJ Gosney
Aug 18, 1981·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S Moncada, J R Vane
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·J E LoydJ H Newman
May 1, 1995·American Journal of Respiratory and Critical Care Medicine·M HumbertD Emilie
May 28, 1994·Annals of the New York Academy of Sciences·N F Voelkel, R Tuder
Dec 1, 1993·British Heart Journal·F BrenotG Simonneau
Jun 17, 1993·The New England Journal of Medicine·A GiaidD J Stewart
Mar 22, 1996·The Journal of Biological Chemistry·A GrazianiP M Comoglio
Jan 1, 1997·American Journal of Respiratory and Critical Care Medicine·J H MorseE Angles-Cano
Mar 15, 1997·The Journal of Clinical Investigation·D D IvyS H Abman
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·R M TuderN F Voelkel
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·J K WangD Trono
Jun 7, 2000·The Journal of Clinical Investigation·S EddahibiS Adnot
May 10, 2002·The European Respiratory Journal·S SantosJ A Barberà
Dec 5, 2002·Physiological Genomics·Yasushi HoshikawaMark W Geraci
Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri

❮ Previous
Next ❯

Citations

Jun 12, 2013·Expert Review of Cardiovascular Therapy·Abraham Samuel BabuRamachandran Padmakumar
Jul 4, 2012·Heart Failure Clinics·Ragavendra R Baliga, James B Young
Jul 4, 2012·Heart Failure Clinics·Robert P Frantz, Michael D McGoon
Apr 27, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Clemens L BockmeyerDanny Jonigk
Feb 24, 2016·Expert Opinion on Drug Discovery·Yon K SungVinicio A de Jesus Perez
Apr 14, 2010·Current Opinion in Anaesthesiology·Chad D Pritts, Ronald G Pearl

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.